Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 123

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 123
---
 expenses payable by us in connection with the sale and distribution of the securities being registered hereby. All amounts shown,
other than the SEC registration fee, are estimates:

| SEC registration fee         | $ | 23,304 |
| Depositary fees and expenses |   |      * |
| Printing and engraving       |   |      * |
| Accounting services          |   |      * |
| Legal fees and expenses      |   |      * |
| Miscellaneous                |   |      * |
| Total                        | $ |      * |

_______________

*These fees are calculated based on the securities offered and number
of issuances and accordingly cannot be defined at this time.

<div align='center'>LEGAL MATTERS</div>

Certain legal matters in connection
with the validity of the securities offered hereby will passed upon for us by Brown Rudnick LLP, London, United Kingdom. Certain other matters of U.S. federal law will be passed upon for us by Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C., Boston, Massachusetts.

| 76 |

<div align='center'>EXPERTS</div>

The financial statements as
of December 31, 2024, and for the year then ended, incorporated by reference into this prospectus and in the registration statement have
been so incorporated in reliance on a report PKF Littlejohn LLP, an independent registered accounting firm, given on authority of said
firm as experts in auditing and accounting. The report on the financial statements for the year ended December 31, 2024 contains an explanatory
paragraph regarding our ability to continue as a going concern.

PKF Littlejohn LLP, London,
United Kingdom, is a member of the Institute of Chartered Accountants in England and Wales.

The financial statements as
of December 31, 2023, and for each of the two years in the period then ended, incorporated by reference into this prospectus and in the
registration statement, have been so incorporated in reliance on a report of Forvis Mazars LLP (then-named Mazars LLP), an independent
registered accounting firm, given on authority of said firm as experts in auditing and accounting. The report on the financial statements
for the year ended December 31, 2023 contains an explanatory paragraph in Note 2 regarding our ability to continue as a going concern.

Forvis Mazars LLP, London,
United Kingdom, is a member of the Institute of Chartered Accountants in England and Wales.

<div align='center